Descending-SHIP2-mediated radiosensitivity enhancement through PI3K/Akt signaling pathway in laryngeal squamous cell carcinoma
Author:
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference14 articles.
1. Cancer statistics, 2016;Siegel;CA Cancer J. Clin.,2016
2. [Radioresistance and targeted radiosensitization of laryngeal carcinoma];Luo;Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi,2014
3. The PI3K/AKT Pathway as a Target for Cancer Treatment;Mayer;Annu. Rev. Med.,2016
4. Phosphatidylinositol 3-kinase/Akt signaling as a key mediator of tumor cell responsiveness to radiation;Toulany;Semin. Cancer Biol.,2015
5. Roles of glucose transporter-1 and the phosphatidylinositol 3‑kinase/protein kinase B pathway in cancer radioresistance (review);Fan;Mol. Med. Rep.,2015
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Role of PI3K/AKT pathway in squamous cell carcinoma with an especial focus on head and neck cancers;Cancer Cell International;2022-08-13
2. Involvement of the A disintegrin and metalloproteinase 9 in oral cancer cell invasion;European Journal of Oral Sciences;2021-03-30
3. Role of long non-coding RNA NEAT1 in the prognosis of prostate cancer patients;Medicine;2020-05-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3